BioNTech (NASDAQ:BNTX) Now Covered by Analysts at Wells Fargo & Company

Analysts at Wells Fargo & Company initiated coverage on shares of BioNTech (NASDAQ:BNTX – Get Free Report) in a research report issued to clients and investors on Wednesday,Briefing.com Automated Import reports. The brokerage set an “overweight” rating and a $170.00 price target on the stock. Wells Fargo & Company‘s price objective points to a potential […]

Leave a Reply

Your email address will not be published.

Previous post AXIS Capital (NYSE:AXS) Upgraded by Wells Fargo & Company to “Equal Weight” Rating
Next post Teachers Retirement System of The State of Kentucky Purchases 33,147 Shares of Jabil Inc. (NYSE:JBL)